90 related articles for article (PubMed ID: 16362926)
1. Robust diagnosis of non-Hodgkin lymphoma phenotypes validated on gene expression data from different laboratories.
Bhanot G; Alexe G; Levine AJ; Stolovitzky G
Genome Inform; 2005; 16(1):233-44. PubMed ID: 16362926
[TBL] [Abstract][Full Text] [Related]
2. A robust meta-classification strategy for cancer diagnosis from gene expression data.
Alexe G; Bhanot G; Venkataraghavan B; Ramaswamy R; Lepre J; Levine AJ; Stolovitzky G
Proc IEEE Comput Syst Bioinform Conf; 2005; ():322-5. PubMed ID: 16447989
[TBL] [Abstract][Full Text] [Related]
3. [Complex diagnosis of follicular lymphomas].
Tóth E; Schneider T; Melegh Z; Csernák E; Udvarhelyi N; Rosta A; Szentirmay Z
Magy Onkol; 2005; 49(2):135-40. PubMed ID: 16249809
[TBL] [Abstract][Full Text] [Related]
4. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
5. Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?
Bosga-Bouwer AG; van den Berg A; Haralambieva E; de Jong D; Boonstra R; Kluin P; van den Berg E; Poppema S
Hum Pathol; 2006 May; 37(5):528-33. PubMed ID: 16647949
[TBL] [Abstract][Full Text] [Related]
6. Logical analysis of diffuse large B-cell lymphomas.
Alexe G; Alexe S; Axelrod DE; Hammer PL; Weissmann D
Artif Intell Med; 2005 Jul; 34(3):235-67. PubMed ID: 16023562
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.
Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA
Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688
[TBL] [Abstract][Full Text] [Related]
8. Histological progression of follicular lymphoma associated with p53 mutation and rearrangement of the C-MYC gene.
Takimoto Y; Takafuta T; Imanaka F; Kuramoto A; Sasaki N; Nanba K
Hiroshima J Med Sci; 1996 Jun; 45(2):69-73. PubMed ID: 8810134
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
10. Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data.
Gui J; Li H
Bioinformatics; 2005 Jul; 21(13):3001-8. PubMed ID: 15814556
[TBL] [Abstract][Full Text] [Related]
11. Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells.
Andréasson U; Dictor M; Jerkeman M; Berglund M; Sundström C; Linderoth J; Rosenquist R; Borrebaeck CA; Ek S
Am J Hematol; 2009 Dec; 84(12):803-8. PubMed ID: 19844990
[TBL] [Abstract][Full Text] [Related]
12. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma.
van den Berg A; Kroesen BJ; Kooistra K; de Jong D; Briggs J; Blokzijl T; Jacobs S; Kluiver J; Diepstra A; Maggio E; Poppema S
Genes Chromosomes Cancer; 2003 May; 37(1):20-8. PubMed ID: 12661002
[TBL] [Abstract][Full Text] [Related]
13. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
Iqbal J; Neppalli VT; Wright G; Dave BJ; Horsman DE; Rosenwald A; Lynch J; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Campo E; Ott G; Müller-Hermelink HK; Delabie J; Jaffe ES; Grogan TM; Connors JM; Vose JM; Armitage JO; Staudt LM; Chan WC
J Clin Oncol; 2006 Feb; 24(6):961-8. PubMed ID: 16418494
[TBL] [Abstract][Full Text] [Related]
14. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis.
Culhane AC; Perrière G; Higgins DG
BMC Bioinformatics; 2003 Nov; 4():59. PubMed ID: 14633289
[TBL] [Abstract][Full Text] [Related]
15. Pathway analysis of informative genes from microarray data reveals that metabolism and signal transduction genes distinguish different subtypes of lymphomas.
Mircean C; Tabus I; Kobayashi T; Yamaguchi M; Shiku H; Shmulevich I; Zhang W
Int J Oncol; 2004 Mar; 24(3):497-504. PubMed ID: 14767533
[TBL] [Abstract][Full Text] [Related]
16. Transformed diffuse large B-cell lymphomas with gains of the discontinuous 12q12-14 amplicon display concurrent deregulation of CDK2, CDK4 and GADD153 genes.
Al-Assar O; Rees-Unwin KS; Menasce LP; Hough RE; Goepel JR; Hammond DW; Hancock BW
Br J Haematol; 2006 Jun; 133(6):612-21. PubMed ID: 16704435
[TBL] [Abstract][Full Text] [Related]
17. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
[TBL] [Abstract][Full Text] [Related]
18. MILANO--custom annotation of microarray results using automatic literature searches.
Rubinstein R; Simon I
BMC Bioinformatics; 2005 Jan; 6():12. PubMed ID: 15661078
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
20. [Histocytologic comparison in the diagnosis of hematosarcomas].
Gérard-Marchant R; Schlumberger JR; Schneider M; Cattan A; Schneiberg K
Sem Hop; 1967 Feb; 43(7):435-8. PubMed ID: 4292919
[No Abstract] [Full Text] [Related]
[Next] [New Search]